Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test.

PHASE3CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Diagnosis of Adult Growth Hormone Deficiency (AGDH)
Interventions
DRUG

AEZS-130 (formerly ARD-07)

A single oral administration of AEZS-130 as Growth Hormone Stimulation Test

DRUG

L-ARG+GHRH

A single administration of L-ARG+GHRH (iv bolus) followed by a 30min infusion of L-ARG as Growth Hormone Stimulation Test

Trial Locations (13)

21287

John Hopkins University, Baltimore

60654

Radiant Research Inc., Chicago

68502

Celerion, Lincoln

77030

Baylor College of Medicine, Houston

85283

Celerion, Tempe

90048

Cedars-Sinai Medical Center, Los Angeles

90502

Harbor-UCLA Medical Center, Torrance

97239

Oregon Health & Science University, Portland

98493

VA Puget Sound HCS University of Washington, Tacoma

60611-3008

Northwestern University, Chicago

02114

Massachusetts General Hospital, Boston

07753

Celerion, Neptune City

78229-4801

Cetero Research, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AEterna Zentaris

INDUSTRY